Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04374474

Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)

Olfactory Retraining Therapy and Budesonide Nasal Rinse for Anosmia Treatment in Patients Post-CoVID 19. A Randomized Controlled Trial

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study will be a randomized controlled trial, involving patients with hyposmia/anosmia of onset immediately after an upper respiratory viral illness, assigned to three distinct study arms. Nasal irrigations will be prescribed to all three groups (BID). In addition, one arm will receive a paper hand-out about post-viral anosmia with instructions to smell common household items (current care) and act as a control group. The second group will receive an essential oil retraining kit, whereas the third group will receive the same olfactory training kit and a prescription to use budesonide with the nasal irrigations. Olfactory scores will be tested at the enrollment, 3 months and at 6 months.

Conditions

Interventions

TypeNameDescription
OTHEROlfactory retrainingOlfactory retraining Olfactory training is performed by exposing patients twice daily to essential oils with four specific odors, present in glass jars with soaked cotton pads: phenyl ethyl alcohol, rose; eucalyptol, eucalyptus; citronellal, lemon; eugenol, cloves.
DRUGcorticosteroid nasal irrigationNasal irrigation with corticosteroid (budesonide) consists of 240-mL nasal irrigation with Pulmicort Respules (0.5mg) across both nose sides via NeilMed Sinus Rinse bottle (Santa Rosa, California, USA).
OTHERsmell household ItemsParticipants will receive a paper hand-out about post-viral anosmia with instructions to smell common household items
OTHERNasal IrrigationParticipants from all three groups will use nasal rinse (NeilMed Sinus Rinse) two times a day.

Timeline

Start date
2021-01-10
Primary completion
2021-12-10
Completion
2022-03-10
First posted
2020-05-05
Last updated
2025-08-01

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04374474. Inclusion in this directory is not an endorsement.